If US Court Says Delta-8 Product Is Lawful And Trademark Valid, Will Federal Agencies Listen?
Executive Summary
Recent 9th Circuit ruling upheld granting a firm preliminary injunction stopping competitor from using its trademarked brand for delta-8 THC products. Ruling generally runs counter to USPTO policy against accepting trademark registrations for hemp or cannabis products and specifically counters FDA stance delta-8 doesn’t meet definition of hemp under 2018 farm bill.
You may also be interested in...
Political Winds, Like Previous Storms Over US FDA Decisions, Stir Around OTC Contraceptive Proposal
Experts spoke with HBW Insight about potential impact on US contraceptive market from Supreme Court’s decision in Dobbs v. Jackson overturning its 1973 ruling in Roe v. Wade, which was upheld in 1992 ruling in Planned Parenthood v. Casey, stating a woman has a constitutional right to reproductive health services.
CBD Will Be US FDA’s ‘One’ Lawful Hemp Compound, House Appropriators Anticipate
Reference in report accompanying House Appropriation Committee bill for FDA FY2023 budget isn’t binding and wasn’t appropriators’ first mention of agency’s response to de-scheduling hemp as a controlled substance. But their ’ statement was more pointed than in previous appropriation reports.
First US Warnings On Drug Claims By Delta-8 THC Supplements Also Describe Safety Concerns
Announcement and warnings, in addition to noting firms’ violative drug and disease claims, explain differences between delta-8 THC and other hemp-derived cannabinoids intended for de-scheduling as controlled substances in 2018 farm bill.